ARTA BIOSCIENCE, INC.
SAINT LOUIS, MO, 63105-2272
|# of Employees:||0|
|Socially and Economically Disadvantaged:||N|
The androgen receptor (AR) remains a key therapeutic target for prostate cancer (PCa), even in castration resistant PCa (CRPC). Current therapies target AR by blocking androgen synthesis or competiti ...SBIRPhase I2011Department of Health and Human Services